alexa Patented Nanopharmaceuticals: A Hope for Patent Expired
ISSN: 2375-4516

Intellectual Property Rights: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


Patented Nanopharmaceuticals: A Hope for Patent Expired Formulations

Usama Ahmad Md Faiyazuddin*

Nano pharmaceutical& Drug Delivery Research Lab (NDDRL), Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, India

*Corresponding Author:
Usama Ahmad Md Faiyazuddin
Assistant Professor and Principal Investigator
Nano pharmaceutical and Drug Delivery Research Lab (NDDRL)
Faculty of Pharmacy, Integral University Lucknow Uttar Pradesh, India
Tel: +91-9044712679
E-mail: [email protected]

Received Date: February 05, 2014; Accepted Date: February 06, 2014; Published Date: February 11, 2014

Citation: Md Faiyazuddin UA (2014) Patented Nano Pharmaceuticals: A Hope for Patent Expired Formulations. Intel Prop Rights 2:e104. doi: 10.4172/2375-4516.1000e104

Copyright: © 2014 Md Faiyazuddin UA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



A lot of medicines are on their way to patent expiration but emergence of nanotechnology in medicines has revolutionized the pharmaceutical industry. Actually, Nano medicine is an exciting multidisciplinary field which involves understanding & application of drugs at the Nano-level. Unique & novel phenomenon is observed when particles are reduced to Nano dimensions. Development of novel nanopharmaceuticals & application of innovative techniques in drug industry needs to be protected. Patents are exclusive rights given to an individual to protect novel creations as a result of one’s intellect. A patentee is awarded certain exclusive rights by which conversion of intellectual creation to commercialization can be protected. As the companies gear up to go smaller in size to achieve better & much more effective Nano medicines, the PTO (Patents & Trademarks Office) strengthens its regulatory charter to tackle any contravention.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version